메뉴 건너뛰기




Volumn 17, Issue 1, 2011, Pages 458-470

Thrombosis and inflammatory bowel disease: A call for improved awareness and prevention

Author keywords

Crohn's disease; heparin; thromboembolic; thrombosis; ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CILOSTAZOL; CLOPIDOGREL; CORTICOSTEROID; CYANOCOBALAMIN; CYCLOSPORIN; D DIMER; DIPYRIDAMOLE; FOLIC ACID; GLUCOCORTICOID; HEPARIN; INFLIXIMAB; LOW MOLECULAR WEIGHT HEPARIN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; OLSALAZINE; STEROID; STREPTOKINASE; TACROLIMUS; THALIDOMIDE; TICLOPIDINE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UROKINASE; VON WILLEBRAND FACTOR; WARFARIN;

EID: 78650119968     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21334     Document Type: Review
Times cited : (88)

References (111)
  • 1
    • 0001837254 scopus 로고
    • Extensive arterial and venous thrombosis complicating chronic ulcerative colitis
    • Bargen JA, Barker NW,. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med. 1936; 58: 17-31.
    • (1936) Arch Intern Med. , vol.58 , pp. 17-31
    • Bargen, J.A.1    Barker, N.W.2
  • 2
    • 0033519051 scopus 로고    scopus 로고
    • Venous thrombosis: A multicausal disease
    • Rosendaal FR,. Venous thrombosis: a multicausal disease. Lancet. 1999; 353: 1167-1173.
    • (1999) Lancet. , vol.353 , pp. 1167-1173
    • Rosendaal, F.R.1
  • 3
    • 0029964844 scopus 로고    scopus 로고
    • Interleukin-6 stimulates coagulation, not fibrinolysis, in humans
    • Stouthard JM, Levi M, Hack CE, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost. 1996; 76: 738-742.
    • (1996) Thromb Haemost. , vol.76 , pp. 738-742
    • Stouthard, J.M.1    Levi, M.2    Hack, C.E.3
  • 4
    • 0029974758 scopus 로고    scopus 로고
    • Hemostatic abnormalities in inflammatory bowel disease
    • Chiarantini E, Valanzano R, Liotta AA, et al. Hemostatic abnormalities in inflammatory bowel disease. Thromb Res. 1996; 82: 137-146.
    • (1996) Thromb Res. , vol.82 , pp. 137-146
    • Chiarantini, E.1    Valanzano, R.2    Liotta, A.A.3
  • 5
    • 0028846736 scopus 로고
    • Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease
    • Souto JC, Martinez E, Roca M, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci. 1995; 40: 1883-1889.
    • (1995) Dig Dis Sci. , vol.40 , pp. 1883-1889
    • Souto, J.C.1    Martinez, E.2    Roca, M.3
  • 6
    • 0029889911 scopus 로고    scopus 로고
    • Determination of prothrombin activation fragments in young patients with inflammatory bowel disease
    • Smith CJ, Haire WD, Kaufman SS, et al. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease. Am J Gastroenterol. 1996; 91: 1221-1225.
    • (1996) Am J Gastroenterol. , vol.91 , pp. 1221-1225
    • Smith, C.J.1    Haire, W.D.2    Kaufman, S.S.3
  • 7
    • 0030864544 scopus 로고    scopus 로고
    • No evidence of activated blood coagulation in Crohn's disease
    • Novacek G, Kapiotis S, Moser G, et al. No evidence of activated blood coagulation in Crohn's disease. Eur J Gastroenterol Hepatol. 1997; 9: 963-967.
    • (1997) Eur J Gastroenterol Hepatol. , vol.9 , pp. 963-967
    • Novacek, G.1    Kapiotis, S.2    Moser, G.3
  • 8
    • 0026598071 scopus 로고
    • Circulating von Willebrand factor in inflammatory bowel disease
    • Stevens TR, James JP, Simmonds NJ, et al. Circulating von Willebrand factor in inflammatory bowel disease. Gut. 1992; 33: 502-506.
    • (1992) Gut. , vol.33 , pp. 502-506
    • Stevens, T.R.1    James, J.P.2    Simmonds, N.J.3
  • 9
    • 0024550636 scopus 로고
    • Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces
    • de Jong E, Porte RJ, Knot EA, et al. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut. 1989; 30: 188-194.
    • (1989) Gut. , vol.30 , pp. 188-194
    • De Jong, E.1    Porte, R.J.2    Knot, E.A.3
  • 10
    • 0031057343 scopus 로고    scopus 로고
    • The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia
    • Levi M, van der Poll T, ten Cate H, et al. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest. 1997; 27: 3-9.
    • (1997) Eur J Clin Invest. , vol.27 , pp. 3-9
    • Levi, M.1    Van Der Poll, T.2    Ten Cate, H.3
  • 11
    • 0037469261 scopus 로고    scopus 로고
    • C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: Implications for the metabolic syndrome and atherothrombosis
    • Devaraj S, Xu DY, Jialal I,. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003; 107: 398-404.
    • (2003) Circulation. , vol.107 , pp. 398-404
    • Devaraj, S.1    Xu, D.Y.2    Jialal, I.3
  • 12
    • 3543127813 scopus 로고    scopus 로고
    • Formation of platelet-leukocyte aggregates in inflammatory bowel disease
    • Irving PM, Macey MG, Shah U, et al. Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10: 361-372.
    • (2004) Inflamm Bowel Dis. , vol.10 , pp. 361-372
    • Irving, P.M.1    MacEy, M.G.2    Shah, U.3
  • 13
    • 17444414959 scopus 로고    scopus 로고
    • Circulating cell-derived microparticles in Crohn's disease
    • Chamouard P, Desprez D, Hugel B, et al. Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci. 2005; 50: 574-580.
    • (2005) Dig Dis Sci. , vol.50 , pp. 574-580
    • Chamouard, P.1    Desprez, D.2    Hugel, B.3
  • 14
    • 0022656226 scopus 로고
    • Vascular complications of inflammatory bowel disease
    • Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986; 61: 140-145.
    • (1986) Mayo Clin Proc. , vol.61 , pp. 140-145
    • Talbot, R.W.1    Heppell, J.2    Dozois, R.R.3
  • 15
    • 0027401535 scopus 로고
    • Thromboembolism in inflammatory bowel disease: Role of platelets
    • Webberley MJ, Hart MT, Melikian V,. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993; 34: 247-251.
    • (1993) Gut. , vol.34 , pp. 247-251
    • Webberley, M.J.1    Hart, M.T.2    Melikian, V.3
  • 16
    • 0014277999 scopus 로고
    • Life histories of patients with chronic ulcerative colitis: A review of 2,000 cases
    • Sloan WP Jr, Bargen JA, Gage RB,. Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases. Gastroenterology. 1968; 54: Suppl: 819-822.
    • (1968) Gastroenterology. , vol.54 , Issue.SUPPL. , pp. 819-822
    • Sloan Jr., W.P.1    Bargen, J.A.2    Gage, R.B.3
  • 17
    • 0035085024 scopus 로고    scopus 로고
    • The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study
    • Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001; 85: 430-434.
    • (2001) Thromb Haemost. , vol.85 , pp. 430-434
    • Bernstein, C.N.1    Blanchard, J.F.2    Houston, D.S.3
  • 18
    • 14644443651 scopus 로고    scopus 로고
    • Risk factors for thromboembolic complications in inflammatory bowel disease: The role of hyperhomocysteinaemia
    • Oldenburg B, Van Tuyl BA, van der Griend R, et al. Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia. Dig Dis Sci. 2005; 50: 235-240.
    • (2005) Dig Dis Sci. , vol.50 , pp. 235-240
    • Oldenburg, B.1    Van Tuyl, B.A.2    Van Der Griend, R.3
  • 19
    • 76749157063 scopus 로고    scopus 로고
    • Venous thromboembolism during active disease and remission in inflammatory bowel disease: A cohort study
    • Grainge MJ, West J, Card TR,. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010; 375: 657-663.
    • (2010) Lancet. , vol.375 , pp. 657-663
    • Grainge, M.J.1    West, J.2    Card, T.R.3
  • 20
    • 37449016439 scopus 로고    scopus 로고
    • The incidence of arterial thromboembolic diseases in inflammatory bowel disease: A population-based study
    • Bernstein CN, Wajda A, Blanchard JF,. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol. 2008; 6: 41-45.
    • (2008) Clin Gastroenterol Hepatol. , vol.6 , pp. 41-45
    • Bernstein, C.N.1    Wajda, A.2    Blanchard, J.F.3
  • 21
    • 12144288479 scopus 로고    scopus 로고
    • Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?
    • Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004; 53: 542-548.
    • (2004) Gut. , vol.53 , pp. 542-548
    • Miehsler, W.1    Reinisch, W.2    Valic, E.3
  • 22
    • 1542493341 scopus 로고    scopus 로고
    • Venous thromboembolism in inflammatory bowel disease
    • Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004; 99: 97-101.
    • (2004) Am J Gastroenterol. , vol.99 , pp. 97-101
    • Solem, C.A.1    Loftus, E.V.2    Tremaine, W.J.3
  • 23
    • 0026579089 scopus 로고
    • Arterial thromboembolic complications of inflammatory bowel disease. Report of three cases
    • Novotny DA, Rubin RJ, Slezak FA, et al. Arterial thromboembolic complications of inflammatory bowel disease. Report of three cases. Dis Colon Rectum. 1992; 35: 193-196.
    • (1992) Dis Colon Rectum. , vol.35 , pp. 193-196
    • Novotny, D.A.1    Rubin, R.J.2    Slezak, F.A.3
  • 24
    • 0025853696 scopus 로고
    • Cerebrovascular complications of inflammatory bowel disease
    • Johns DR,. Cerebrovascular complications of inflammatory bowel disease. Am J Gastroenterol. 1991; 86: 367-370.
    • (1991) Am J Gastroenterol. , vol.86 , pp. 367-370
    • Johns, D.R.1
  • 25
    • 0024842920 scopus 로고
    • Budd-Chiari syndrome and Crohn's disease. An unreported association
    • Maccini DM, Berg JC, Bell GA,. Budd-Chiari syndrome and Crohn's disease. An unreported association. Dig Dis Sci. 1989; 34: 1933-1936.
    • (1989) Dig Dis Sci. , vol.34 , pp. 1933-1936
    • MacCini, D.M.1    Berg, J.C.2    Bell, G.A.3
  • 26
    • 0018292292 scopus 로고
    • Cerebral and retinal vascular complications of inflammatory bowel disease
    • Schneiderman JH, Sharpe JA, Sutton DM,. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol. 1979; 5: 331-337.
    • (1979) Ann Neurol. , vol.5 , pp. 331-337
    • Schneiderman, J.H.1    Sharpe, J.A.2    Sutton, D.M.3
  • 27
    • 0028048123 scopus 로고
    • Retinal vascular disease in ulcerative colitis
    • Keyser BJ, Hass AN,. Retinal vascular disease in ulcerative colitis. Am J Ophthalmol. 1994; 118: 395-396.
    • (1994) Am J Ophthalmol. , vol.118 , pp. 395-396
    • Keyser, B.J.1    Hass, A.N.2
  • 28
    • 11144319481 scopus 로고    scopus 로고
    • Mesenteric venous thrombosis in inflammatory bowel disease
    • Hatoum OA, Spinelli KS, Abu-Hajir M, et al. Mesenteric venous thrombosis in inflammatory bowel disease. J Clin Gastroenterol. 2005; 39: 27-31.
    • (2005) J Clin Gastroenterol. , vol.39 , pp. 27-31
    • Hatoum, O.A.1    Spinelli, K.S.2    Abu-Hajir, M.3
  • 29
    • 26244444347 scopus 로고    scopus 로고
    • Cerebral sinus thrombosis in patients with inflammatory bowel disease: A case report
    • Umit H, Asil T, Celik Y, et al. Cerebral sinus thrombosis in patients with inflammatory bowel disease: a case report. World J Gastroenterol. 2005; 11: 5404-5407.
    • (2005) World J Gastroenterol. , vol.11 , pp. 5404-5407
    • Umit, H.1    Asil, T.2    Celik, Y.3
  • 30
    • 1642533660 scopus 로고    scopus 로고
    • Cerebral venous thrombosis in acute inflammatory bowel disease
    • 206.
    • Singh G, Sarkar S, Manoj K, et al. Cerebral venous thrombosis in acute inflammatory bowel disease. Gut. 2004; 53: 161, 206.
    • (2004) Gut. , vol.53 , pp. 161
    • Singh, G.1    Sarkar, S.2    Manoj, K.3
  • 31
    • 27644460489 scopus 로고    scopus 로고
    • Increased carotid intima-media thickness in patients with inflammatory bowel disease
    • Papa A, Santoliquido A, Danese S, et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005; 22: 839-846.
    • (2005) Aliment Pharmacol Ther. , vol.22 , pp. 839-846
    • Papa, A.1    Santoliquido, A.2    Danese, S.3
  • 32
    • 70349256406 scopus 로고    scopus 로고
    • Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: A case report and review of the literature
    • Fabi SG, Hill C, Witherspoon JN, et al. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature. J Drugs Dermatol. 2009; 8: 765-769.
    • (2009) J Drugs Dermatol. , vol.8 , pp. 765-769
    • Fabi, S.G.1    Hill, C.2    Witherspoon, J.N.3
  • 34
    • 33646883735 scopus 로고    scopus 로고
    • Efficacy of prophylactic warfarin for prevention of thalidomide-related deep venous thrombosis
    • Ikhlaque N, Seshadri V, Kathula S, et al. Efficacy of prophylactic warfarin for prevention of thalidomide-related deep venous thrombosis. Am J Hematol. 2006; 81: 420-422.
    • (2006) Am J Hematol. , vol.81 , pp. 420-422
    • Ikhlaque, N.1    Seshadri, V.2    Kathula, S.3
  • 35
    • 0023644095 scopus 로고
    • Fibrinogen and risk of cardiovascular disease
    • the Framingham Study
    • Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987; 258: 1183-1186.
    • (1987) JAMA , vol.258 , pp. 1183-1186
    • Kannel, W.B.1    Wolf, P.A.2    Castelli, W.P.3
  • 36
    • 0021210911 scopus 로고
    • Fibrinogen as a risk factor for stroke and myocardial infarction
    • Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984; 311: 501-505.
    • (1984) N Engl J Med. , vol.311 , pp. 501-505
    • Wilhelmsen, L.1    Svardsudd, K.2    Korsan-Bengtsen, K.3
  • 37
    • 0022485106 scopus 로고
    • Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
    • Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986; 2: 533-537.
    • (1986) Lancet. , vol.2 , pp. 533-537
    • Meade, T.W.1    Mellows, S.2    Brozovic, M.3
  • 38
    • 0022317310 scopus 로고
    • Plasma fibrinogen-a major coronary risk factor
    • Stone MC, Thorp JM,. Plasma fibrinogen-a major coronary risk factor. J R Coll Gen Pract. 1985; 35: 565-569.
    • (1985) J R Coll Gen Pract. , vol.35 , pp. 565-569
    • Stone, M.C.1    Thorp, J.M.2
  • 39
    • 0022908186 scopus 로고
    • Blood rheology in arterial disease
    • Lowe GD,. Blood rheology in arterial disease. Clin Sci (Lond). 1986; 71: 137-146.
    • (1986) Clin Sci (Lond). , vol.71 , pp. 137-146
    • Lowe, G.D.1
  • 40
    • 0017070372 scopus 로고
    • Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides
    • Vassalli JD, Hamilton J, Reich E,. Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell. 1976; 8: 271-281.
    • (1976) Cell. , vol.8 , pp. 271-281
    • Vassalli, J.D.1    Hamilton, J.2    Reich, E.3
  • 41
    • 0017651179 scopus 로고
    • Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors
    • Granelli-Piperno A, Vassalli JD, Reich E,. Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med. 1977; 146: 1693-1706.
    • (1977) J Exp Med. , vol.146 , pp. 1693-1706
    • Granelli-Piperno, A.1    Vassalli, J.D.2    Reich, E.3
  • 42
    • 0021134150 scopus 로고
    • The effects of betamimetics and glucocorticoids on fetal vascular prostacyclin and platelet thromboxane synthesis in humans
    • Makila UM,. The effects of betamimetics and glucocorticoids on fetal vascular prostacyclin and platelet thromboxane synthesis in humans. Prostaglandins Leukot Med. 1984; 16: 11-17.
    • (1984) Prostaglandins Leukot Med. , vol.16 , pp. 11-17
    • Makila, U.M.1
  • 43
    • 0017890459 scopus 로고
    • Lack of effect of prednisone administration on bleeding time and platelet function of normal subjects
    • Thong KL, Mant MJ, Grace MG,. Lack of effect of prednisone administration on bleeding time and platelet function of normal subjects. Br J Haematol. 1978; 38: 373-380.
    • (1978) Br J Haematol. , vol.38 , pp. 373-380
    • Thong, K.L.1    Mant, M.J.2    Grace, M.G.3
  • 44
    • 0022572140 scopus 로고
    • Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells
    • Lewis GD, Campbell WB, Johnson AR,. Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology. 1986; 119: 62-69.
    • (1986) Endocrinology. , vol.119 , pp. 62-69
    • Lewis, G.D.1    Campbell, W.B.2    Johnson, A.R.3
  • 45
    • 0028606887 scopus 로고
    • Corticosteroids: Do they damage the cardiovascular system?
    • Maxwell SR, Moots RJ, Kendall MJ,. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J. 1994; 70: 863-870.
    • (1994) Postgrad Med J. , vol.70 , pp. 863-870
    • Maxwell, S.R.1    Moots, R.J.2    Kendall, M.J.3
  • 46
    • 33846407948 scopus 로고    scopus 로고
    • Risk factors and clinical impact of postoperative symptomatic venous thromboembolism
    • discussion 341-332.
    • Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007; 45: 335-341; discussion 341-332.
    • (2007) J Vasc Surg. , vol.45 , pp. 335-341
    • Gangireddy, C.1    Rectenwald, J.R.2    Upchurch, G.R.3
  • 47
    • 33846036404 scopus 로고    scopus 로고
    • Inflammation and coagulation in inflammatory bowel disease: The clot thickens
    • Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol. 2007; 102: 174-186.
    • (2007) Am J Gastroenterol. , vol.102 , pp. 174-186
    • Danese, S.1    Papa, A.2    Saibeni, S.3
  • 48
    • 0033801479 scopus 로고    scopus 로고
    • Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease
    • Carty E, MacEy M, Rampton DS,. Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment Pharmacol Ther. 2000; 14: 1169-1179.
    • (2000) Aliment Pharmacol Ther. , vol.14 , pp. 1169-1179
    • Carty, E.1    MacEy, M.2    Rampton, D.S.3
  • 49
    • 0033798272 scopus 로고    scopus 로고
    • Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease
    • Fagerstam JP, Whiss PA, Strom M, et al. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease. Inflamm Res. 2000; 49: 466-472.
    • (2000) Inflamm Res. , vol.49 , pp. 466-472
    • Fagerstam, J.P.1    Whiss, P.A.2    Strom, M.3
  • 50
    • 0023635639 scopus 로고
    • Lack of effect of 5-aminosalicylic acid on platelet aggregation and fibrinolytic activity in vivo and in vitro
    • Winther K, Bondesen S, Hansen SH, et al. Lack of effect of 5-aminosalicylic acid on platelet aggregation and fibrinolytic activity in vivo and in vitro. Eur J Clin Pharmacol. 1987; 33: 419-422.
    • (1987) Eur J Clin Pharmacol. , vol.33 , pp. 419-422
    • Winther, K.1    Bondesen, S.2    Hansen, S.H.3
  • 51
    • 33947314966 scopus 로고    scopus 로고
    • CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon
    • Vowinkel T, Anthoni C, Wood KC, et al. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon. Gastroenterology. 2007; 132: 955-965.
    • (2007) Gastroenterology. , vol.132 , pp. 955-965
    • Vowinkel, T.1    Anthoni, C.2    Wood, K.C.3
  • 53
    • 34247877467 scopus 로고    scopus 로고
    • Vascular and cellular stress in inflammatory bowel disease: Revisiting the role of homocysteine
    • Peyrin-Biroulet L, Rodriguez-Gueant RM, Chamaillard M, et al. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol. 2007; 102: 1108-1115.
    • (2007) Am J Gastroenterol. , vol.102 , pp. 1108-1115
    • Peyrin-Biroulet, L.1    Rodriguez-Gueant, R.M.2    Chamaillard, M.3
  • 54
    • 0033635087 scopus 로고    scopus 로고
    • Oral tacrolimus treatment of severe colitis in children
    • Bousvaros A, Kirschner BS, Werlin SL, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr. 2000; 137: 794-799.
    • (2000) J Pediatr. , vol.137 , pp. 794-799
    • Bousvaros, A.1    Kirschner, B.S.2    Werlin, S.L.3
  • 55
    • 0027965108 scopus 로고
    • Long-term efficacy and safety of cyclosporine in renal-transplant recipients
    • Burke JF Jr, Pirsch JD, Ramos EL, et al. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med. 1994; 331: 358-363.
    • (1994) N Engl J Med. , vol.331 , pp. 358-363
    • Burke Jr., J.F.1    Pirsch, J.D.2    Ramos, E.L.3
  • 56
    • 0026048757 scopus 로고
    • Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability
    • Fishman SJ, Wylonis LJ, Glickman JD, et al. Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability. J Surg Res. 1991; 51: 93-98.
    • (1991) J Surg Res. , vol.51 , pp. 93-98
    • Fishman, S.J.1    Wylonis, L.J.2    Glickman, J.D.3
  • 57
    • 0030174289 scopus 로고    scopus 로고
    • Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood
    • Bombeli T, Muller M, Straub PW, et al. Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood. J Lab Clin Med. 1996; 127: 621-634.
    • (1996) J Lab Clin Med. , vol.127 , pp. 621-634
    • Bombeli, T.1    Muller, M.2    Straub, P.W.3
  • 58
    • 0021881063 scopus 로고
    • Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients
    • Vanrenterghem Y, Roels L, Lerut T, et al. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet. 1985; 1: 999-1002.
    • (1985) Lancet. , vol.1 , pp. 999-1002
    • Vanrenterghem, Y.1    Roels, L.2    Lerut, T.3
  • 59
    • 24944493338 scopus 로고    scopus 로고
    • A case of cyclosporine-induced dural sinus thrombosis
    • Al-Shekhlee A, Oghlakian G, Katirji B,. A case of cyclosporine-induced dural sinus thrombosis. J Thromb Haemost. 2005; 3: 1327-1328.
    • (2005) J Thromb Haemost. , vol.3 , pp. 1327-1328
    • Al-Shekhlee, A.1    Oghlakian, G.2    Katirji, B.3
  • 60
    • 3042658278 scopus 로고    scopus 로고
    • Cerebral sinus thrombosis associated with severe active ulcerative colitis
    • Murata S, Ishikawa N, Oshikawa S, et al. Cerebral sinus thrombosis associated with severe active ulcerative colitis. Intern Med. 2004; 43: 400-403.
    • (2004) Intern Med. , vol.43 , pp. 400-403
    • Murata, S.1    Ishikawa, N.2    Oshikawa, S.3
  • 61
    • 0023038704 scopus 로고
    • Increased incidence of renal allograft thrombosis under cyclosporine immunosuppression
    • Rigotti P, Flechner SM, Van Buren CT, et al. Increased incidence of renal allograft thrombosis under cyclosporine immunosuppression. Int Surg. 1986; 71: 38-41.
    • (1986) Int Surg. , vol.71 , pp. 38-41
    • Rigotti, P.1    Flechner, S.M.2    Van Buren, C.T.3
  • 62
    • 33749125866 scopus 로고    scopus 로고
    • Subclinical inflammation and prothrombotic state in heart transplant recipients: Impact of cyclosporin microemulsion vs. tacrolimus
    • White M, Ross H, Haddad H, et al. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. Transplantation. 2006; 82: 763-770.
    • (2006) Transplantation. , vol.82 , pp. 763-770
    • White, M.1    Ross, H.2    Haddad, H.3
  • 63
    • 0023553252 scopus 로고
    • Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine- antilymphocyte globulin
    • Gruber SA, Pescovitz MD, Simmons RL, et al. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin. Transplantation. 1987; 44: 775-778.
    • (1987) Transplantation. , vol.44 , pp. 775-778
    • Gruber, S.A.1    Pescovitz, M.D.2    Simmons, R.L.3
  • 64
    • 0037006627 scopus 로고    scopus 로고
    • Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study
    • DOI 10.1016/S0140-6736(02)07875-3
    • Margreiter R,. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet. 2002; 359: 741-746. (Pubitemid 34215073)
    • (2002) Lancet , vol.359 , Issue.9308 , pp. 741-746
    • Margreiter, R.1
  • 65
    • 38549102077 scopus 로고    scopus 로고
    • TNF-mediated inflammatory disease
    • Bradley JR,. TNF-mediated inflammatory disease. J Pathol. 2008; 214: 149-160.
    • (2008) J Pathol. , vol.214 , pp. 149-160
    • Bradley, J.R.1
  • 66
    • 32044474228 scopus 로고    scopus 로고
    • TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: A novel anti-inflammatory mechanism of infliximab in Crohn's disease
    • Danese S, Sans M, Scaldaferri F, et al. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol. 2006; 176: 2617-2624.
    • (2006) J Immunol. , vol.176 , pp. 2617-2624
    • Danese, S.1    Sans, M.2    Scaldaferri, F.3
  • 67
    • 33751334334 scopus 로고    scopus 로고
    • Safety of infliximab and other biologic agents in the inflammatory bowel diseases
    • Reddy JG, Loftus EV Jr,. Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Gastroenterol Clin North Am. 2006; 35: 837-855.
    • (2006) Gastroenterol Clin North Am. , vol.35 , pp. 837-855
    • Reddy, J.G.1    Loftus Jr., E.V.2
  • 68
    • 4444246999 scopus 로고    scopus 로고
    • Extensive forearm deep venous thrombosis following a severe infliximab infusion reaction
    • Ryan BM, Romberg M, Wolters F, et al. Extensive forearm deep venous thrombosis following a severe infliximab infusion reaction. Eur J Gastroenterol Hepatol. 2004; 16: 941-942.
    • (2004) Eur J Gastroenterol Hepatol. , vol.16 , pp. 941-942
    • Ryan, B.M.1    Romberg, M.2    Wolters, F.3
  • 69
    • 0033586755 scopus 로고    scopus 로고
    • Activated protein C resistance and factor v Leiden mutation are independent risk factors for venous thromboembolism
    • Rodeghiero F, Tosetto A,. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med. 1999; 130: 643-650.
    • (1999) Ann Intern Med. , vol.130 , pp. 643-650
    • Rodeghiero, F.1    Tosetto, A.2
  • 70
    • 0028931717 scopus 로고
    • High risk of thrombosis in patients homozygous for factor v Leiden (activated protein C resistance)
    • Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995; 85: 1504-1508.
    • (1995) Blood. , vol.85 , pp. 1504-1508
    • Rosendaal, F.R.1    Koster, T.2    Vandenbroucke, J.P.3
  • 71
    • 0031761730 scopus 로고    scopus 로고
    • Factor v Leiden mutation is not increased in patients with inflammatory bowel disease
    • Zauber NP, Sabbath-Solitare M, Rajoria G, et al. Factor V Leiden mutation is not increased in patients with inflammatory bowel disease. J Clin Gastroenterol. 1998; 27: 215-216.
    • (1998) J Clin Gastroenterol. , vol.27 , pp. 215-216
    • Zauber, N.P.1    Sabbath-Solitare, M.2    Rajoria, G.3
  • 72
    • 0032979156 scopus 로고    scopus 로고
    • Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease
    • Novacek G, Miehsler W, Kapiotis S, et al. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am J Gastroenterol. 1999; 94: 685-690.
    • (1999) Am J Gastroenterol. , vol.94 , pp. 685-690
    • Novacek, G.1    Miehsler, W.2    Kapiotis, S.3
  • 73
    • 34548672796 scopus 로고    scopus 로고
    • Factor v Leiden and the etiology of inflammatory bowel disease
    • Spek CA, ten Kate FJ, te Velde AA,. Factor V Leiden and the etiology of inflammatory bowel disease. Thromb Haemost. 2007; 98: 670-673.
    • (2007) Thromb Haemost. , vol.98 , pp. 670-673
    • Spek, C.A.1    Ten Kate, F.J.2    Te Velde, A.A.3
  • 74
    • 0029850530 scopus 로고    scopus 로고
    • A common genetic variation in the 3â-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
    • Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3â-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88: 3698-3703.
    • (1996) Blood. , vol.88 , pp. 3698-3703
    • Poort, S.R.1    Rosendaal, F.R.2    Reitsma, P.H.3
  • 75
    • 0031847816 scopus 로고    scopus 로고
    • Increased risk for venous thrombosis in carriers of the prothrombin G->A20210 gene variant
    • Margaglione M, Brancaccio V, Giuliani N, et al. Increased risk for venous thrombosis in carriers of the prothrombin G->A20210 gene variant. Ann Intern Med. 1998; 129: 89-93.
    • (1998) Ann Intern Med. , vol.129 , pp. 89-93
    • Margaglione, M.1    Brancaccio, V.2    Giuliani, N.3
  • 76
    • 0033869354 scopus 로고    scopus 로고
    • Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis
    • Vecchi M, Sacchi E, Saibeni S, et al. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci. 2000; 45: 1465-1469.
    • (2000) Dig Dis Sci. , vol.45 , pp. 1465-1469
    • Vecchi, M.1    Sacchi, E.2    Saibeni, S.3
  • 77
    • 0036145049 scopus 로고    scopus 로고
    • Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease
    • Bjerregaard LT, Nederby NJ, Fredholm L, et al. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002; 37: 62-67.
    • (2002) Scand J Gastroenterol. , vol.37 , pp. 62-67
    • Bjerregaard, L.T.1    Nederby, N.J.2    Fredholm, L.3
  • 78
    • 0033938933 scopus 로고    scopus 로고
    • Inflammatory bowel disease promotes venous thrombosis earlier in life
    • Grip O, Svensson PJ, Lindgren S,. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol. 2000; 35: 619-623.
    • (2000) Scand J Gastroenterol. , vol.35 , pp. 619-623
    • Grip, O.1    Svensson, P.J.2    Lindgren, S.3
  • 79
    • 0343807499 scopus 로고    scopus 로고
    • Prothrombotic inherited abnormalities other than factor v Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease
    • Guedon C, Le Cam-Duchez V, Lalaude O, et al. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease. Am J Gastroenterol. 2001; 96: 1448-1454.
    • (2001) Am J Gastroenterol. , vol.96 , pp. 1448-1454
    • Guedon, C.1    Le Cam-Duchez, V.2    Lalaude, O.3
  • 80
    • 0030895756 scopus 로고    scopus 로고
    • Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor v Leiden
    • Jackson LM, O'Gorman PJ, O'Connell J, et al. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM. 1997; 90: 183-188.
    • (1997) QJM , vol.90 , pp. 183-188
    • Jackson, L.M.1    O'Gorman, P.J.2    O'Connell, J.3
  • 81
    • 0026439018 scopus 로고
    • Free protein S deficiency in patients with chronic inflammatory bowel disease
    • Aadland E, Odegaard OR, Roseth A, et al. Free protein S deficiency in patients with chronic inflammatory bowel disease. Scand J Gastroenterol. 1992; 27: 957-960.
    • (1992) Scand J Gastroenterol. , vol.27 , pp. 957-960
    • Aadland, E.1    Odegaard, O.R.2    Roseth, A.3
  • 82
    • 33845252483 scopus 로고    scopus 로고
    • A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: Data from Turkey
    • Yilmaz S, Bayan K, Tuzun Y, et al. A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey. J Thromb Thrombolysis. 2006; 22: 205-212.
    • (2006) J Thromb Thrombolysis. , vol.22 , pp. 205-212
    • Yilmaz, S.1    Bayan, K.2    Tuzun, Y.3
  • 83
    • 0029143073 scopus 로고
    • Antiphospholipid antibodies in inflammatory bowel disease
    • Souto JC, Borrell M, Fontcuberta J, et al. Antiphospholipid antibodies in inflammatory bowel disease. Dig Dis Sci. 1995; 40: 1524-1525.
    • (1995) Dig Dis Sci. , vol.40 , pp. 1524-1525
    • Souto, J.C.1    Borrell, M.2    Fontcuberta, J.3
  • 85
    • 0031771785 scopus 로고    scopus 로고
    • Anti-cardiolipin and anti-beta2-glycoprotein i antibodies in patients with inflammatory bowel disease
    • Koutroubakis IE, Petinaki E, Anagnostopoulou E, et al. Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci. 1998; 43: 2507-2512.
    • (1998) Dig Dis Sci. , vol.43 , pp. 2507-2512
    • Koutroubakis, I.E.1    Petinaki, E.2    Anagnostopoulou, E.3
  • 86
    • 0031593869 scopus 로고    scopus 로고
    • High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: A pathogenic link with thromboembolic complications?
    • Cattaneo M, Vecchi M, Zighetti ML, et al. High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost. 1998; 80: 542-545.
    • (1998) Thromb Haemost. , vol.80 , pp. 542-545
    • Cattaneo, M.1    Vecchi, M.2    Zighetti, M.L.3
  • 87
    • 69949103268 scopus 로고    scopus 로고
    • The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: Results of the MEGA case-control study
    • van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009; 339: b2921.-
    • (2009) BMJ , vol.339
    • Van Hylckama Vlieg, A.1    Helmerhorst, F.M.2    Vandenbroucke, J.P.3
  • 88
    • 12444304442 scopus 로고    scopus 로고
    • Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study
    • Mitchell L, Andrew M, Hanna K, et al. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Thromb Haemost. 2003; 90: 235-244.
    • (2003) Thromb Haemost. , vol.90 , pp. 235-244
    • Mitchell, L.1    Andrew, M.2    Hanna, K.3
  • 89
    • 4243382688 scopus 로고    scopus 로고
    • The sensitivity and specificity of lineograms and ultrasound compared to venography for the diagnosis of central venous line related thrombosis in symptomatic children: The LUV study [abstract
    • Chait P, Dinyari M, Massicotte MP,. The sensitivity and specificity of lineograms and ultrasound compared to venography for the diagnosis of central venous line related thrombosis in symptomatic children: the LUV study [abstract]. Thromb Haemost. 2001;(suppl): P697.
    • (2001) Thromb Haemost. , Issue.SUPPL.
    • Chait, P.1    Dinyari, M.2    Massicotte, M.P.3
  • 90
    • 0036152065 scopus 로고    scopus 로고
    • Magnetic resonance venography in assessing venous patency after multiple venous catheters
    • Shankar KR, Abernethy LJ, Das KS, et al. Magnetic resonance venography in assessing venous patency after multiple venous catheters. J Pediatr Surg. 2002; 37: 175-179.
    • (2002) J Pediatr Surg. , vol.37 , pp. 175-179
    • Shankar, K.R.1    Abernethy, L.J.2    Das, K.S.3
  • 91
    • 0030963804 scopus 로고    scopus 로고
    • Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate
    • Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, et al. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J. 1997; 134: 479-487.
    • (1997) Am Heart J. , vol.134 , pp. 479-487
    • Ribeiro, A.1    Lindmarker, P.2    Juhlin-Dannfelt, A.3
  • 92
    • 32844466981 scopus 로고    scopus 로고
    • Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: Randomised placebo controlled trial
    • Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006; 332: 325-329.
    • (2006) BMJ , vol.332 , pp. 325-329
    • Cohen, A.T.1    Davidson, B.L.2    Gallus, A.S.3
  • 93
    • 4143085802 scopus 로고    scopus 로고
    • Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
    • Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004; 110: 874-879.
    • (2004) Circulation. , vol.110 , pp. 874-879
    • Leizorovicz, A.1    Cohen, A.T.2    Turpie, A.G.3
  • 94
    • 0033539025 scopus 로고    scopus 로고
    • A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group
    • Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999; 341: 793-800.
    • (1999) N Engl J Med. , vol.341 , pp. 793-800
    • Samama, M.M.1    Cohen, A.T.2    Darmon, J.Y.3
  • 95
    • 46049090201 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th ed
    • Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th ed. Chest. 2008; 133: 381S-453S.
    • (2008) Chest. , vol.133
    • Geerts, W.H.1    Bergqvist, D.2    Pineo, G.F.3
  • 97
    • 0028949781 scopus 로고
    • Inherited disorders of coagulation appear to protect against inflammatory bowel disease
    • Thompson NP, Wakefield AJ, Pounder RE,. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology. 1995; 108: 1011-1015.
    • (1995) Gastroenterology. , vol.108 , pp. 1011-1015
    • Thompson, N.P.1    Wakefield, A.J.2    Pounder, R.E.3
  • 98
    • 0028814834 scopus 로고
    • Paradoxical response to heparin in 10 patients with ulcerative colitis
    • Gaffney PR, Doyle CT, Gaffney A, et al. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol. 1995; 90: 220-223.
    • (1995) Am J Gastroenterol. , vol.90 , pp. 220-223
    • Gaffney, P.R.1    Doyle, C.T.2    Gaffney, A.3
  • 99
    • 0032975985 scopus 로고    scopus 로고
    • Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease
    • Folwaczny C, Wiebecke B, Loeschke K,. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol. 1999; 94: 1551-1555.
    • (1999) Am J Gastroenterol. , vol.94 , pp. 1551-1555
    • Folwaczny, C.1    Wiebecke, B.2    Loeschke, K.3
  • 100
    • 0030816854 scopus 로고    scopus 로고
    • Treatment of corticosteroid-resistant ulcerative colitis with heparin-a report of 16 cases
    • Evans RC, Wong VS, Morris AI, et al. Treatment of corticosteroid- resistant ulcerative colitis with heparin-a report of 16 cases. Aliment Pharmacol Ther. 1997; 11: 1037-1040.
    • (1997) Aliment Pharmacol Ther. , vol.11 , pp. 1037-1040
    • Evans, R.C.1    Wong, V.S.2    Morris, A.I.3
  • 101
    • 0033852957 scopus 로고    scopus 로고
    • Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease
    • Ang YS, Mahmud N, White B, et al. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther. 2000; 14: 1015-1022.
    • (2000) Aliment Pharmacol Ther. , vol.14 , pp. 1015-1022
    • Ang, Y.S.1    Mahmud, N.2    White, B.3
  • 102
    • 0032847644 scopus 로고    scopus 로고
    • Low molecular weight heparin as adjuvant therapy in active ulcerative colitis
    • Torkvist L, Thorlacius H, Sjoqvist U, et al. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther. 1999; 13: 1323-1328.
    • (1999) Aliment Pharmacol Ther. , vol.13 , pp. 1323-1328
    • Torkvist, L.1    Thorlacius, H.2    Sjoqvist, U.3
  • 103
    • 0034794370 scopus 로고    scopus 로고
    • Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: An open trial
    • Dotan I, Hallak A, Arber N, et al. Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial. Dig Dis Sci. 2001; 46: 2239-2244.
    • (2001) Dig Dis Sci. , vol.46 , pp. 2239-2244
    • Dotan, I.1    Hallak, A.2    Arber, N.3
  • 104
    • 0033777998 scopus 로고    scopus 로고
    • Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis
    • Panes J, Esteve M, Cabre E, et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology. 2000; 119: 903-908.
    • (2000) Gastroenterology. , vol.119 , pp. 903-908
    • Panes, J.1    Esteve, M.2    Cabre, E.3
  • 105
    • 11144358357 scopus 로고    scopus 로고
    • Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis
    • Bloom S, Kiilerich S, Lassen MR, et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther. 2004; 19: 871-878.
    • (2004) Aliment Pharmacol Ther. , vol.19 , pp. 871-878
    • Bloom, S.1    Kiilerich, S.2    Lassen, M.R.3
  • 106
    • 33646240158 scopus 로고    scopus 로고
    • Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: A randomized, controlled, comparative study
    • Zezos P, Papaioannou G, Nikolaidis N, et al. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther. 2006; 23: 1443-1453.
    • (2006) Aliment Pharmacol Ther. , vol.23 , pp. 1443-1453
    • Zezos, P.1    Papaioannou, G.2    Nikolaidis, N.3
  • 107
    • 34250357545 scopus 로고    scopus 로고
    • Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis
    • de Bievre MA, Vrij AA, Schoon EJ, et al. Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis. 2007; 13: 753-758.
    • (2007) Inflamm Bowel Dis. , vol.13 , pp. 753-758
    • De Bievre, M.A.1    Vrij, A.A.2    Schoon, E.J.3
  • 108
    • 34547844145 scopus 로고    scopus 로고
    • Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis
    • Shen J, Ran ZH, Tong JL, et al. Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis. Aliment Pharmacol Ther. 2007; 26: 653-663.
    • (2007) Aliment Pharmacol Ther. , vol.26 , pp. 653-663
    • Shen, J.1    Ran, Z.H.2    Tong, J.L.3
  • 109
    • 0033519974 scopus 로고    scopus 로고
    • Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease
    • Day R, Forbes A,. Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet. 1999; 354: 62-65.
    • (1999) Lancet. , vol.354 , pp. 62-65
    • Day, R.1    Forbes, A.2
  • 110
    • 0000477658 scopus 로고    scopus 로고
    • Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin
    • Cui HF, Jiang XL,. Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin. World J Gastroenterol. 1999; 5: 448-450.
    • (1999) World J Gastroenterol. , vol.5 , pp. 448-450
    • Cui, H.F.1    Jiang, X.L.2
  • 111
    • 48449091370 scopus 로고    scopus 로고
    • Oral, colonic-release low-molecular-weight heparin: An initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis
    • Pastorelli L, Saibeni S, Spina L, et al. Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis. Aliment Pharmacol Ther. 2008; 28: 581-588.
    • (2008) Aliment Pharmacol Ther. , vol.28 , pp. 581-588
    • Pastorelli, L.1    Saibeni, S.2    Spina, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.